TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Delivered Single-pool Kt/Vurea (spKt/V)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Upper Limb Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health Anxiety Inventory score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety and tolerability of single or multiple doses of SUVN-D4010
Endpoint domain: Adverse events/effects
Primary endpoint: CD8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Completion of All the Intervention Content
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: number of positive swab cultures
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of classical radiation induced liver disease (RILD)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of transplant complication
Endpoint domain: Adverse events/effects
Primary endpoint: Qualification Rate for Permanent System Implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Q-wave MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stroke (hemorrhagic or ischemic)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: [18F]FES PET/CT Uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total aggression score of the CMAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative number of T cells reactive to melanoma peptides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Chronic low back pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum proteomic profile in hand osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Static Balance Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of symptom scores from urodynamic studies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NAC Total Nasal Symptom Score (TNSS) Area under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic Brain derived neurotrophic factor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adolescent treatment engagement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Force control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Change in Total Brody/CF-CT Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission of KHE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in liking of activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety Level of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Urinary infection in the child
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Predictive Accuracy of Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biodex Isokinetic Muscle Strength Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: DNA methylation profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality within 30 days of randomization
Endpoint domain: Mortality/survival
Primary endpoint: Number of days off work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvements of adipokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ventricular Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tolerability of Suprascapular and Median Nerve Blocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Blood Oxygen Level Dependent (BOLD) Signal Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rZ Change Score in Resting State Functional Connectivity From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reaching (Toy Contact Duration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early Problem Solving Indicator (EPSI)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Variations in growth or macroscopic tumor volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: % HIV entry into foreskin derived CD4+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of subjects with electrocardiogram (ECG) findings of potential clinical importance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of subjects with vital signs findings of potential clinical importance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase of Hemoglobin Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increase of Platelet Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of complete ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in mean high-sensitivity C-reactive protein (hsCRP) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in mean interleukin-6 (IL-6) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pharmacokinetic profile of midazolam and its 1' hydroxy metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic profile of caffeine and its paraxanthine [3-desmethyl] metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Responders of Low Anterior Resection Syndrome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: proportion of patients with seroconversion HBe
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HBV DNA below 2.3 log10 copies per ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility measured using a validated satisfaction questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility measured using a validated health economics survey
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility measured using qualitative interviews
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CTO Crossing Success Using the Wildcat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With a Grade 3 or Higher TEAE
Endpoint domain: Adverse events/effects
Primary endpoint: long term safety profile of pramlintide treatment
Endpoint domain: Adverse events/effects
Primary endpoint: long-term effect on body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-rated function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain-rating
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Investigator irritation grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Peak percent de novo palmitate in blood triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Functional differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal change in prostate cancer cell proliferation (Ki-67)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Apoptosis rates (cleaved caspase-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Eczema Area and Severity Index-75 (EASI-75) Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction of the severity of trauma-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of stones in common bile duct
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent Change in Plasma Angiotensinogen (AGT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Shulman fasciitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in myokines/adipokine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Transition to full oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of major depressive disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of anxiety disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fasting Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of subjects reporting solicited local adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects reporting solicited systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Serum ALP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum phosphate level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake and adherence with hip protectors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Protected and unprotected falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ratio of Choline/ Creatine (CHO/CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ratio of Myoinositol/ Creatine (MI/CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brain Temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum aluminum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of patients no longer fulfilling criteria for an eating disorder diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of inferior alveolar nerve injury
Endpoint domain: Adverse events/effects
Primary endpoint: Root exposure
Endpoint domain: Adverse events/effects
Primary endpoint: Periapical lesion
Endpoint domain: Adverse events/effects
Primary endpoint: Lab values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Xray of Chest and sinus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of cardiac stem cell cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak Expiratory Flow Rate (PEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change From Baseline in Total Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in 'Care for Chronic Conditions' scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of infants with diaper rash episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative delivered energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Viral load change from baseline to end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants Experiencing Clinical and Laboratory Adverse Events (CAEs and LAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Change From Baseline in Hepatic Glucose Production (HGP) at Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MMP-2, MMP-9 and NGAL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: miRNAs levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change in number of daily hot flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in the intensity of daily hot flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of pain intensity score at post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of disability score at post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline of quality of life score at post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Effect on sitting times
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Urinary KIM-1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative UIVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative UNVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of recurrent inspiratory muscle training
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Total Tic Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in drug abuse consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment efficacy of breast fibroadenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Composite of Net Adverse Clinical Endpoint (NACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in ETDRS visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of postprandial High Amplitude Propagated Contractions (HAPCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in postprandial tone relative to fasting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Glipizide Response - Area Over the Glucose Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glipizide Response - Area Under the Insulin Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metformin Response - Change in Fasting Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metformin Response - Change in HOMA-IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of the FEEDBACK system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fundamental frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV transmission risk behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PET Scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rating Scales
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean change in fractional absorption of calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence Rate of Adverse Events/Adverse Drug Reactions (AE/ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: AUC of YM178
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of YM178
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t1/2 of YM178
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in ALT level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Number of patients with interpretable images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days until liberation from mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Osteoradionecrosis rate
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Potentially Clinically Significant Laboratory Evaluation Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Potentially Clinically Significant Electrocardiogram (ECG) Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum tolerated dose of becatecarin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction Time on the Multi-Source Interference Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Percent Drop in FEV1 for Late-Phase Asthma Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Oxytocin level in human blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Ability to form appropriate grasp patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Visual Analog Scale for Energy (VAS-E) Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of patients with clinically changes in vital signs (blood pressure [BP], pulse rate [PR])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 13CO2 concentration in expired air
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 24-hour gastric pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in serum C-reactive protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in probing pocket depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Are in Remission at 36 and 48 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EMG activity of posterior rotator cuff
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of Fatigue Symptom
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: myocardial ischemia assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Histologic regression of CIN 2/3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: VLDL-TG storage in adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Physiological abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Downregulation of Th1 cytokine TNFalpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in HRQOL from baseline to T2
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in HRQOL from baseline across a 12-month interval
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Perceived Stress from baseline to T2
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Perceived Stress from baseline across a 12-month interval
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disease Recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Improvement of Mentoring Skills
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Timely vaccination visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Optimum dose of Methylene Blue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interstitial fluid-to-serum ratio for LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cholesterol level in skin biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Symptom Severity Scale (SSS) of the Boston Carpal Tunnel Questionnaire (BCTQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Experiencing Treatment-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiovascular Fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gross Weekly Purchasing of Fruits and Vegetables
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Aerobic capacity and physical function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No infections within 30 days postoperatively
Endpoint domain: Adverse events/effects
Primary endpoint: Rapid Shallow Breathing Index (RSBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes